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ABSTRACT
The Cockayne Syndrome group B (CSB) protein
plays important roles in transcription, transcription-
coupled nucleotide excision repair and base exci-
sion DNA repair. c-Abl kinase also plays a role in
DNA repair as a regulator/coordinator of the DNA
damage response. This study presents evidence
that the N-terminal region of CSB interacts with the
SH3 domain of c-Abl in vitro and in vivo. In addition,
c-Abl kinase phosphorylates CSB at Tyr932. The
subcellular localization of CSB to the nucleus and
nucleolus is altered after phosphorylation by c-Abl.
c-Abl-dependent phosphorylation of CSB increased
in cells treated with hydrogen peroxide and
decreased in cells pre-treated with STI-571, a
c-Abl-specific protein kinase inhibitor. Activation
of the c-Abl kinase in response to oxidative damage
is not observed in CSB null cells. These results
suggest that c-Abl and CSB may regulate each other
in a reciprocal manner in response to oxidative
stress.
INTRODUCTION
Cockayne Syndrome (CS) is a hereditary human disease
characterized by profound deﬁciency of post-natal growth
with heterogeneity of clinical symptoms and neural
degeneration resembling premature aging. CS is asso-
ciated with defective transcription-coupled nucleotide
excision repair (1). At the cellular/molecular level, the
phenotype of CS includes sensitivity to ultraviolet
(UV)-irradiation and delayed recovery of RNA and
DNA synthesis after exposure to UV (2–4) There are
two CS complementation groups, A and B (5), corre-
sponding to genetic defects in the CSA and CSB genes,
respectively. The CSB gene encodes a 168-kDa protein
which is a member of the SWI/SNF family of DNA-
dependent ATPases (6). Previous studies show that
primary cells from CS patients have a defect in initiating
(i.e. incision) repair of oxidative DNA lesions (7). In
addition, cells that are deﬁcient in CSB-dependent ATPase
(motif VI mutants) are sensitive to g-irradiation and
defective in general genome repair of oxidative DNA
damage (8,9). These data suggest that CSB may play a role
in repair of oxidative DNA damage via the base excision
repair (BER) pathway.
c-Abl is a non-receptor protein tyrosine kinase whose
activities are tightly regulated in the cell. For example,
both nuclear and cytoplasmic c-Abl is activated in
response to genotoxic or oxidative stress (10), DNA
damage (11–14), or by a protein kinase Cd (PKCd)-
dependent mechanism (15). Activated c-Abl plays a role in
inducing apoptosis and/or necrosis (16,17) after exposure
to oxidative and other types of cellular stress. c-Abl is
phosphorylated by DNA-PK (18,19) and interacts with
DNA repair associated proteins (20–23) including p53,
p73 and Rad9 (24–26). Oxidative stress activates
c-Abl (27,28).
Structure-function analysis of c-Abl indicates that it has
a protein–protein interaction SH3 domain, which is likely
to participate in interactions between c-Abl and its kinase
substrates. SH3 domains bind preferentially to proline-
rich motifs such as P-X-X-P (29,30) (Figure 2B). CSB is a
phosphoprotein with an N-terminal proline-rich region
(Figure 2E). No prior reports have indicated that CSB
undergoes tyrosine phosphorylation.
Tyrosine phosphorylation, particularly by c-Abl
tyrosine kinase, has been reported to play a role in the
Present address:
Syed Z. Imam, South Texas Veterans Health Care System and Departments of Medicine & Pharmacology, University of Texas, Health Science
Center, San Antonio, TX, 78229,USA
*To whom correspondence should be addressed. Tel: þ1-410-558-8162; Fax: þ1-410-558-8157; Email: vbohr@nih.gov
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.regulation of some DNA repair proteins. c-Abl-mediated
phosphorylation of DNA-topoisomerase I (topo I) at
Tyr268 in vitro and in cells conferred activation of the
topo I function (31). Moreover, activation of c-Abl by
treatment of cells with ionizing radiation was associated
with c-Abl-dependent phosphorylation of topo I and
induction of topo I activity (31). Rad51 is a key element of
recombinational DNA repair and its activity is regulated
by phosphorylation of the tyrosine residue at position 315
by c-Abl tyrosine kinase (32). This study explores the
interactions between c-Abl and CSB and the role of this
interaction in the response to oxidative DNA damage.
Evidence is presented that CSB binds to c-Abl and is a
substrate for c-Abl tyrosine kinase. We speculate that
tyrosine phosphorylation of CSB plays an important role
in regulating and/or coordinating the cellular response to
oxidative stress.
EXPERIMENTAL PROCEDURES
Cellcultures
CS1AN.S3.G2 (CS1AN) cells, a SV40- transformed
human CS-B ﬁbroblast, either with empty vector or
complemented with wild-type CSB, E646Q, Q942E point
mutants, ECFP-CSB were cultured in Dulbecco’s mod-
iﬁed Eagle’s medium containing 10% fetal bovine serum,
50U of penicillin/ml, 50mg of streptomycin/ml and 50mg
of genetectin/ml or neomycin (ECFP-CSB). K562 lym-
phoblasts were cultured in RPMI medium 1640 containing
10% fetal bovine serum and antibiotics. CS1AN cells,
mouse wild-type and c-Abl-/- embryonic ﬁbroblats were
cultured in Dulbecco’s modiﬁed Eagle medium containing
10% fetal bovine serum, 50U of penicillin/ml and 50mg
of streptomycin/ml. GM00969, AG08470, AG01428 and
AG05012 primary ﬁbroblasts were grown to conﬂuence in
minimum essential medium containing 15% FBS, 2X
MEM non-essential amino acids, 2X MEM vitamins and
1X MEM essential amino acids. The human cells were
from the American Type Culture Collection (Manassas,
VA) or Coriell Cell Repositories (Camden, NJ). In some
experiments, CS1AN and CSB-WT complemented cells
were incubated with hydrogen peroxide (Sigma, St. Louis,
MO) in serum-free media at a concentration of 250mM for
1h, either in the presence or absence of STI-571 (5mM).
Proteins and antibodies
The puriﬁed HA/His-tagged CSB protein, GST–c-Abl–Src
homology domain 2 (SH2) and SH3 fragments and the
puriﬁed histidine-tagged c-Abl from a baculovirus insect
expression system were prepared as previously described
(33,34). The c-Abl fragment (45 kDa, containing the SH2
and kinase domains, SH2-PTK) was purchased from New
England BioLabs (Beverly, MA) and a human active
almost full-length c-Abl was purchased from Upstate
technologies (Beverly, MA).
Rabbit anti-human c-Abl was purchased from
Sigma (St. Louis, MO). Cy3-conjugated secondary
mAbs were purchased from Jackson Immunoresearch
Laboratories (West Grove, PA). Mouse anti-GFP, Alexa
488-conjugated secondary mAbs and the DNA stain
40,6-diamidino-2-phenylindole, dihydrochloride (DAPI)
were purchased from Molecular Probes (Eugene, OR).
Immunoprecipitation and immunoblot analysis
Procedures for preparing cell lysates and conducting
immunoprecipitation and immunoblot analysis were
described previously (35). The pre-cleared lysates were
immunoprecipitated with rabbit polyclonal anti-CSB
(H-300; Santa Cruz biotechnology, Santa Cruz, CA) or
mouse monoclonal anti-Abl (8E9; BD Pharmingen)
antibodies. The protein G Sepharose-precipitated proteins
were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS–PAGE), transferred to polyvi-
nylidene diﬂuoride membranes, and analyzed by immuno-
blotting with anti-CSB, anti-Abl (8E9; BD Pharmingen),
or anti-phosphotyrosine (Upstate Technology, Beverly,
MA) monoclonal antibodies followed by the chemilumi-
nescent method for detection with SuperSignal substrates
(Pierce, Rockford, IL). Membranes were stripped by using
the Restore western blot stripping buﬀer (Pierce,
Rockford, IL) when necessary. Anti-CSB immunopreci-
pitates were used either to study the interactions or to
analyze in vivo tyrosine phosphorylation. Anti-Abl immu-
noprecipitates were used either to study the interactions
or to analyze in vivo tyrosine phosphorylation or in in vitro
kinase assays using GST–Crk (aa 120–225) as c-Abl
substrate.
GST pull-down experiments
The CSB and GST–c-Abl fragments and GST was
incubated and the adsorbents were analyzed by SDS–
PAGE. The membrane was analyzed by immunoblotting
with the monoclonal anti-HA or anti-c-Abl antibody.
Also, GST–c-Abl and GST was incubated with HeLa
whole cell extracts (1mg/ml) and the adsorbents were
analyzed by SDS–PAGE. The membrane was analyzed by
immunoblotting with the polyclonal anti-CSB or stained
with amido black.
S-protein pull-down experiments
CS1AN cells were transfected with cDNA (6mg)
expressing various S-tagged fragments of CSB protein
(Figure 2C) for 30h with the PolyFect reagent (Qiagen,
Valencia, CA). Whole cell extracts were prepared as
described above. Equal amount of proteins were subjected
to S-protein pull down using S-protein conjugated agarose
beads (Novagen). The pull-down products were centri-
fuged at 500 g for 2min to collect the beads and washed
ﬁve times with ice-cold lysis buﬀer. The ﬁnal bead pellets
were either used to incubate with full-length human c-Abl
for binding studies or for in vitro kinase assay.
Microscopy and immunofluorescence
Cells were fractionated in situ to remove the cytoskeleton
according to Mirzoeva and Petrini (36), and then were
processed for indirect immunoﬂuorescence and analyzed
as described in Partridge et al. (37). For quantiﬁcation,
images were analyzed with co-localization software (Zeiss)
using the exact same set of criteria for all cells.
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For in vitro kinase assays, the puriﬁed CSB was incubated
with the c-Abl fragment, mouse full-length c-Abl or
human full-length GST-c-Abl or GST-c-Abl (K-R) in a
kinase buﬀer (50mM Tris–HCl, 10mM MgCl2,1 m M
EGTA, 2mM dithiothreitol) for 15min at 288C. The
c-Abl kinase inhibitor STI-571 (Novartis Pharma AG)
(38) was used as a control. Phosphorylated proteins
were separated by SDS–PAGE and analyzed by
immunoblotting.
For in vivo phosphorylation, CSB-WT or CS1AN cells
(2.4 10
6 cells/10cm culture dish) were transfected with
6mg of wild-type c-Abl or the dominant-negative c-Abl
(K-R) mutant vectors (39) for 30h with the PolyFect
reagent (Qiagen, Valencia, CA). The cells were lysed
as described above. Equal amount of protein from the
whole cell extracts was used to immunoprecipitates CSB
followed by phosphotyrosine analysis. Whole cell extracts
were also immunoblotted to detect c-Abl, and CSB.
Tyrosine-phosphorylation mapping by MALDI-MS
analysis
MALDI-MS analysis was used to identify the tyrosine-
phosphorylation site of CSB. In brief, in vitro kinase assay
was done as described above. The phosphorylated
proteins were separated on 4–20% Tris–HCl gel by
SDS–PAGE. The gel was then stained with Commassie
blue stain. The bands were then excised and subjected to
in-gel tryptic digestion (Pierce, Rickford, IL) according to
the manufacturer’s instructions.
The digests were then subjected to phosphopeptide
isolation using a phosphopeptide isolation kit (Pierce,
Rockford, IL). Elutes were subjected to MALDI-MS
analysis. Mass spectra were collected on a Voyager
MALDI-TOF mass spectrometer using delayed extraction
parameter. The eluted phosphopeptide mixtures were
analyzed in reﬂector mode. 70–200 shots from a nitrogen
laser (337nm) were averaged to yield each recorded mass
spectrum. Spectra were externally calibrated with angio-
tensin I (MH
þ¼1296.6853) and adrenocorticotropic
hormone fragment (7–38; MH
þ¼3657.93). The matrix
solution was prepared immediately before use by mixing
20mg of a-cyano-4-hydroxycinnamic acid and 4mg of
2,5-dihydroxybenzoic acid in 500ml of 0.1% triﬂuoroace-
tic acid in 50% CH3CN/dH2O, vortexing for 1min,
centrifuging for 1min, and subsequently diluting the
clear supernatant 1:4 with 0.1% TFA in 50% CH3CN/
dH2O. Five microliters of the diluted matrix solution was
mixed with the eluted tyrosine-phosphorylated peptides,
and a 1ml suspension was spotted on the target and
allowed to air-dry completely before mass analysis.
For interpretation of the mass spectra, a list of
predicted molecular weights was generated by theoretical
cleavage with trypsin as a speciﬁc endoproteinases using
the MS-Digest program available at the University of
California, San Francisco (http://prospector.ucsf.edu/
ucsfhtml3.2/msdigest.htm). The masses of the peaks
recorded in the mass spectra were matched to the
calculated masses within  0.1% or better.
RESULTS
Physicalinteraction between CSB and c-Abl
Physical interaction between puriﬁed CSB and c-Abl
was examined in vitro using GST-pull-down or
co-immunoprecipitation assays (Figure 1A, 1B and 1C).
GST-pull-down products revealed that CSB and c-Abl
interact with each other in vitro (Figure 1A). A GST-pull-
down assay using GST-c-Abl and HeLa whole cell
extracts (1mg/ml) also revealed a potential interaction
between c-Abl and endogenous CSB (Figure 1B). In vivo
assays were also performed with extracts of CSB-deﬁcient
CS1AN cells or CS1AN cells complemented with
wild-type CSB. Immunoprecipitation was carried out
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Figure 1. Physical interaction between CSB and c-Abl. (A) GST
pull-down assay of puriﬁed HA-tagged CSB and GST-c-Abl. (B) GST
pull-down assay of GST-c-Abl and HeLa whole cell extracts (WCE,
1mg/ml). (C) Immunoprecipitation with anti-c-Abl antibody from the
whole cell lysates (2-mg protein) obtained from CS1AN cells either
complemented with wild-type CSB or an empty vector. Pull-down
products or immunocomplex were separated by SDS–PAGE and the
resulting blot was immunoblotted with respective antibodies as
indicated in the ﬁgure.
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Figure 2. Identiﬁcation of binding domains of CSB and c-Abl. c-Abl interacts with N-terminal of CSB via its SH3 domain. (A) GST pull-down assay
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were blotted with anti-CSB. The results suggest that
CSB interacts with c-Abl in vivo in CS1AN cells expressing
wild-type CSB (Figure 1C).
The region of c-Abl that interacts with CSB was
identiﬁed by incubating CSB with GST fusion proteins
carrying the SH2 or the SH3 signaling domain of c-Abl.
The results show that CSB binds to GST-c-Abl-SH3
(Figure 2A). Although we were not able to see any
interaction of SH2 domain of c-Abl with CSB, there is a
possibility of transient interaction of the SH2 domain with
CSB. This interaction mapping was analyzed in more
detail using S-protein tagged fragments of CSB. The
results demonstrate that the N-terminal region of CSB,
which includes proline-rich residues 301–304, interacts
with the SH3 domain of c-Abl (Figure 2C, D and E).
S-protein tagged CSB fragments (Figure 2C) were used in
an alternate pull-down assay, which also indicated that the
N-terminal region of CSB interacts with the SH3 domain
of c-Abl (Figure 2C, D and E).
c-Abl phosphorylates CSB invitro and invivo
To determine whether CSB is a substrate for c-Abl, an
in vitro kinase assay was performed by incubating CSB
with a truncated form of c-Abl including its SH2 and
protein tyrosine kinase domains (SH2-PTK). The results
show that phosphotyrosine (p-Tyr) accumulates in CSB in
the presence of active c-Abl kinase (SH2-PTK) but not in
the presence of heat-inactivated c-Abl (SH2-PTK), a full-
length kinase inactive c-Abl mutant (GST-c-Abl K-R), or
after pre-incubation of either SH2-PTK fragment or full-
length c-Abl with the kinase inhibitor STI-571 (Figure 3A
and C). (Note that the amount of CSB protein was similar
after phosphotyrosinylation; Figure 3A.) The kinase
activities of full-length human c-Abl (Figure 3B) and
human GST-c-Abl also phosphorylate CSB (Figure 3C).
However, GST-c-Abl (K-R) failed to tyrosine phosphor-
ylate CSB (Figure 3C). The location(s) of phosphotyrosine
residues in SH2-PTK phosphorylated CSB were identiﬁed
using an in vitro kinase assay with immunocomplexed
S-protein fragments of CSB. The results indicate that
phosphotyrosine is located only in CSB fragment aa
465–1056 (Figure 3D). The conserved ATPase and heli-
case motifs of CSB are also located in this region of CSB.
The ability of c-Abl to phosphorylate CSB in vivo was
examined in CSB-deﬁcient CS1AN cells expressing ectopic
wild-type CSB. These cells were transfected with a plasmid
expressing c-Abl or kinase-inactive c-Abl (K-R). CSB
immunoprecipitates had signiﬁcantly more phosphotyro-
sine in cells expressing c-Abl than in cells expressing c-Abl
(K-R) or in cells that were not overexpressing c-Abl
(Figure 3E). A low level of tyrosine phosphorylation was
evident in cells expressing c-Abl (K-R), which could
be due to endogenous c-Abl phosphorylation of CSB
(Figure 3E). These results indicate that c-Abl tyrosine-
phosphorylates CSB in vitro and in vivo and are consistent
with the possibility that CSB is a physiologically
important substrate of c-Abl.
CSB tyrosine-phosphorylation was also examined in
chronic myeloid leukemia (CML) K562 lymphoblasts,
which have a constitutive high level of Abl tyrosine kinase
activity. These cells have been shown to express both
cytoplasmic and nuclear c-Abl (40). CSB immunoprecipi-
tates from whole cell extracts of these cells are signiﬁcantly
tyrosine-phosphorylated and the amount of phosphoryla-
tion is reduced if cells are pre-treated with STI-571
(Figure 3F). Similarly, CSB is tyrosine-phosphorylated
in wild-type mouse embryonic ﬁbroblasts (MEFs) but not
in Abl-/- MEFs (Figure 3G). The amount of phosphotyr-
osine incorporated into CSB increased in MEFs exposed
to oxidative stress and this increase was blocked by pre-
treatment with STI-571 (Figure 3G). These data conﬁrm
the speciﬁcity of c-Abl for CSB and suggest that CSB may
be a preferred substrate of c-Abl in cells exposed to
oxidative stress.
c-Abl phosphorylates CSB at Tyr 932
The tyrosine phosphorylation site of CSB was mapped at
the amino acid level by MALDI-MS analysis of tryptic
fragments of tyrosine-phosphorylated CSB. This experi-
ment was carried out using the product of an in vitro
kinase reaction containing c-Abl and CSB. The assay
product was resolved by SDS–PAGE and digested by
trypsin in situ. Phosphopeptides were eluted from the gel,
concentrated using phosphopetide columns and analyzed
by MALDI-MS (Figure 4). The peptides obtained from
full-length CSB had a 95–99% match frequency with 59%
coverage of full-length CSB. Mass analysis of each peptide
indicated that a phosphate group was added to a 2262
kDa peptide VVIYDPDWNPSTDTQARER (929–947);
this peptide contains Tyr932 (Figure 4B). Treatment with
alkaline phosphatase released the phosphate moiety from
the putative phosphotyrosine 932, suggesting correct
identiﬁcation of the peptide structure and correct mapping
of tyrosine phosphorylation in CSB (Figure 4C). Tyr932 is
located in motif VI of the putative ATPase/helicase
domain of CSB.
CSBand c-Abl co-localize after oxidative damage
Indirect immunoﬂuorescence of CSIAN cells expressing
ECFP-CSB indicate that c-Abl (red, Figure 5) and CSB
(green, Figure 5) are present throughout the nucleus in a
punctate pattern in non-treated cells (Control). After
exposure to hydrogen peroxide (H2O2), expression of
ECFP-CSB and c-Abl increase and they re-distribute and
co-localize in the nucleus and nucleolus (yellow in Merge,
Figure 5). These eﬀects can be inhibited with STI-571
(H2O2þSTI, Figure 5). These data raise the possibility
that tyrosine phosphorylation of CSB by c-Abl promotes
redistribution of CSB in the nucleus and enrichment of
CSB in the nucleolus in response to oxidative stress;
furthermore, these events may require c-Abl tyrosine
kinase activity. Interestingly, when similar experiments
were performed in CSB-deﬁcient CS1AN cells (Bottom
Panel, Figure 5), c-Abl redistribution to the nucleolus was
not observed in response to oxidative stress. This result
suggests that c-Abl and CSB might play complementary
roles in a stress-response pathway that is activated by
oxidative damage. Table 1 presents the quantitation of the
data observed in Figure 5.
Nucleic Acids Research, 2007, Vol. 35, No. 15 4945CSB 200 ng
c-Abl SH2-PTK
STI-571
CSB
c-Abl
CSB
CSB
c-Abl c-Abl K-R
CSB
c-Abl
A
B
C
IB:p-Tyr
CSB
CSB
IB:CSB
c-Abl
Abl
CSB
STI-571
IB:c-Abl
c-Abl
IB:p-Tyr
IB:c-Abl
IB:S-protein
2
-
3
4
1
3
1
0
-
5
2
0
4
6
6
-
1
0
5
6
1
1
8
7
-
1
4
9
3
9
5
3
-
1
2
0
4 D
CSB Fragments
IB:p-Tyr
IB:CSB
IB:CSB
IB:p-Tyr
+
++
+
−+ + +
−+ − −
+
+
+++−
CS1AN.WTCSB
c-Abl
c-Abl (K-R)
+++
−+−
−−+
−+
−++−++
−−+−−+
−+
CSB
c-Abl
CSB
E
STI-571
IP: CSB
IB: p-Tyr
IB: CSB
IB: p-Tyr
Input
IB: CSB
F
H2O2
STI-571
Abl −/− MEFs WT MEFs
IP: CSB
IB: p-Tyr
G
IB: c-Abl
K562 CML Cells
IB: p-Tyr
IB: c-Abl
IB: CSB
IB: CSB
Figure 3. CSB is phosphorylated by c-Abl in vitro and in vivo. Kinase assays were done by incubating puriﬁed CSB proteins with (A) increasing
concentrations of SH2-PTK fragment of c-Abl (5, 10 and 20ng), (B) full-length human-c-Abl protein (50 and 100ng), and (C) full length human
c-Abl protein or kinase-dead (K-R) c-Abl protein (50 and 100ng). Phosphorylated proteins were separated by SDS–PAGE, transferred to a PVDF
membrane, followed by immunoblotting for tyrosine phosphorylation using anti-p-Tyr. STI-571: kinase inhibitor (100nM), þ: present,  : absent,
m: heat-inactivated c-Abl. (D) Kinase assays were done by incubating SH2-PTK fragment of c-Abl (20ng) with S-protein pull-down products of
whole cell extracts obtained from CS1AN cells transfected with S-protein tagged fragments of CSB. The resultant product was analyzed for
phosphotyrosine (top panel), or c-Abl (middle panel) or S-protein (bottom panel). (E) c-Abl phosphorylates CSB in vivo. Wild-type CSB
complemented CS1AN cells were either transfected with c-Abl or c-Abl (K-R) expression vectors. CSB was immunoprecipitated and anti-CSB
immunoprecipitates were subjected to immunoblotting with anti-p-tyrosine antibody. Cell lysates were also immunoblotted with anti-c-Abl and
anti-CSB antibodies. þ: present,  : absent. (F) Anti-CSB immunoprecipitates from K562 CML lymphoblasts were analyzed for phosphotyrosine
(top panel) or for CSB (bottom panel). (G) Anti-CSB immunoprecipitates either from wild-type or Abl /  MEFs were analyzed for phosphotyrosine
(top panel) or for c-Abl (bottom panel).
4946 Nucleic Acids Research, 2007, Vol. 35, No. 15Oxidative-stress induces c-Abl mediated tyrosine
phosphorylation of CSBand CSB isnecessary for
activation ofc-Abl after oxidative damage
As stated above, we postulate that the interaction between
CSB and c-Abl and the phosphorylation of CSB by c-Abl
may play a role in the response to oxidative stress in vivo.
This idea was tested by examining the eﬃciency of
oxidative stress-induced c-Abl phosphorylation and
autophosphorylation in the presence of wild-type and
mutant forms of CSB. CS1AN cells expressing wild-type
CSB, motif II E646Q CSB (ATPase-deﬁcient) or motif VI
Q942E CSB (BER-deﬁcient) or no CSB were exposed to
H2O2 and CSB phosphorylation and c-Abl autophos-
phorylation were examined. Autophosphorylation of
c-Abl was signiﬁcantly induced in cells expressing wild-
type (WT) CSB and motif VI mutant CSB but not in
cells expressing the CSB motif II mutant (Figure 6A).
Tyrosine-phosphorylation increased signiﬁcantly for WT
Figure 4. c-Abl phosphorylates CSB at Tyrosine 932. Puriﬁed CSB was phosphorylated by SH2-PTK domain on c-Abl in an in vitro kinase assay.
Phosphorylated proteins were separated by SDS–PAGE. In-gel tryptic digestion was performed to digest phosphorylated CSB. Phosphopeptides were
concentrated using phosphopeptide isolation column. The eluates were analyzed by MALDI-MS and the spectra were collected in reﬂector mode.
Mass analysis of each peptide indicated that a phosphate group was added to a 2262kDa peptide VVIYDPDWNPSTDTQARER (929–947); this
peptide contains Tyr932 (A) CSB alone, (B) tyrosine-phosphorylated CSB and (C) tyrosine phosphorylated CSB after phosphatase treatment.
Nucleic Acids Research, 2007, Vol. 35, No. 15 4947CSB, but less for the motif VI mutant and not at all for the
motif II mutant of CSB. Pre-treatment with STI-571
(5mM) completely blocked c-Abl auto-phosphorylation
and c-Abl mediated tyrosine phosphorylation of CSB
(Figure 6A). c-Abl and CSB protein levels were similar in
all cell extracts (Figure 6B). c-Abl auto-phosphorylation
and tyrosine-phosphorylation of CSB was observed in
normal human primary ﬁbroblasts exposed to H2O2,
but not in primary ﬁbroblasts from CS patients
(Figure 6C). Oxidative damage did not result in Abl
auto-phosphorylation or tyrosine-phosphorylation of
CSB in AG05012 or AG01428 primary ﬁbroblasts
obtained from CS patients. However, a signiﬁcant
auto-phosphorylation of c-Abl followed by a resultant
tyrosine phosphorylation of CSB was observed in
GM00969 and AG08470 ﬁbroblasts derived from matched
normal human subjects, after oxidative damage
(Figure 6C). Pre-treatment with STI-571 inhibited auto-
phosphorylation of c-Abl and tyrosine-phosphorylation of
CSB (Figure 6C). These data suggest that CSB stimulates
auto-phosphorylation of c-Abl and its activation in
response to oxidative stress; this in turn results in tyrosine
phosphorylation of CSB itself.
It is possible that auto-phosphorylation of c-Abl in
response to oxidative damage inﬂuences c-Abl activity in a
CSB-dependent manner. This idea was tested by measuring
oxidative stress-induced c-Abl kinase activity towards a
15 amino acid fragment of Crk (aa 120–225) conjugated to
GST in extracts of CS1AN cells with an ectopic plasmid
expressing wild-type CSB. The results show that auto-
phosphorylation of c-Abl increased in response to oxida-
tive stress in extracts of CS1AN cells expressing wild type
CSB but not in extracts of control cells carrying empty
vector. Furthermore, activation/autophosphorylation of
c-Abl stimulated tyrosine-phosphorylation of GST–Crk
(aa 120–225) (Figure 6D). Pre-treatment with STI-571
inhibited c-Abl autophosphorylation and c-Abl-mediated
tyrosine-phosphorylation of GST–Crk (aa 120–225)
(Figure 6D). In order to decrease the possibility of
phosphorylation by c-Abl immunoprecipitates from rest-
ing cells, low amounts of protein was used in these studies
for immunoprecipitating c-Abl for kinase activity.
DISCUSSION
This study provides the ﬁrst evidence of a physical
interaction between CSB, a protein involved in the
transcription-coupled DNA nucleotide excision DNA
repair pathway, and the non-receptor tyrosine kinase c-
Abl. CSB interacts with and is tyrosine phosphorylated by
c-Abl in vitro and in vivo. Serine and threonine phosphor-
ylation of CSB were reported previously (41), but this is
the ﬁrst report of tyrosine phosphorylation of CSB.
Tyrosine-phosphorylated CSB is constitutive in CML
K562 lymphoblasts. Also, wild-type MEFs exposed to
hydrogen peroxide have increased CSB tyrosine-phos-
phorylation while it is lacking in Abl-/- MEFs. Tyrosine
932, which lies inmotifVIoftheATPasedomainofCSB,is
Table 1. Quantitative analysis of images in Figure 5
No of Pixels; NT¼100 No of Foci; NT¼100
Groups Green (CSB)
% Increase
Red (c-Abl)
% Increase
Yellow
(co-localization)
% Increase
% co-localizing
yellow pixels/CSB
(green) pixels
No. of co-localizing foci % Increase
NT 100.00 100.00 100.00 7.7 24.0 100.0
H2O2 400.9 439.0 943.9 18.1 226.0 941.7
STIþH2O2 125.0 108.1 100.0 6.1 25.0 104.2
Note: (i) There is a 4-fold increase over non-treated (NT) cells in both CSB (green) and c-Abl (red) signal after H2O2 treatment. A similar increase in
signal was observed in CSB immunoprecipitates of H2O2 vs NT cells. (ii) There is an almost 10-fold increase in co-localization after H2O2 treatment,
both in the number of co-localizing (yellow) pixels and in the number of co-localizing foci. (iii) STI-571 treated cells neither show an increase in
signal intensity nor in co-localization, indicating the abrogation of the CSB-Abl interaction seen after H2O2 treatment, after use of the STI inhibitor.
These results are similar to those obtained by immunoprecipitation.
Figure 5. CSB and c-Abl co-localize after H2O2 treatment. CSIAN cells
complemented with ECFP-tagged WT CSB were processed for indirect
immunoﬂuorescence as described in Methods and stained with rabbit
anti-c-Abl (1:40, red), anti-GFP1 mAb (1:200, green), and the DNA
stain DAPI (blue). 0.1mm Z-sections were obtained on an Axioplan 2i
microscope (Carl Zeiss) and deconvolved with Openlab deconvolution
software. Merge is the merged image of the three ﬂuorescence channels
examined of the same deconvolved Z-section. The bottom panel
represents non-complemented CS1AN cells processed for indirect
immunoﬂuoresecence and stained with rabbit anti-c-Abl (1:40, red),
serving as a comparative control. A representative cell from diﬀerent
experiments is shown.  630; bar, 5mm. An area of the H2O2 treated
cells was enlarged (3 , square) and the arrowheads represent examples
of co-localizing foci. Table 1 presents the quantitative analysis of
images represented in this ﬁgure.
4948 Nucleic Acids Research, 2007, Vol. 35, No. 15the site of CSB phosphorylation by c-Abl. Oxidative stress
stimulates c-Abl-mediated phosphorylation of CSB and
this event is blocked by STI-571, a speciﬁc inhibitor of
c-Abl kinase. Oxidative stress-induced c-Abl auto-
phosphorylation and tyrosine phosphorylation of CSB
appear to require CSB ATPase, because it was not
observed in cells expressing an ATPase-deﬁcient mutant
of CSB. These data suggest that CSB and c-Abl may
participate in and possibly regulate a common oxidative
stress-response pathway.
c-Abl is a tightly regulated non-receptor tyrosine kinase
that contains a Src homology domain 3 (SH3). The SH3
domain is a protein–protein interaction region which
usually binds to proline-rich motifs (P-X-X-P) (42,43).
This study shows that the interaction between c-Abl
and CSB is mediated by the c-Abl SH3 domain and
the N-terminal 355 amino acids of CSB (aa 1–355).
This region of CSB includes a proline-rich motif at aa
301–304 (PVTP).
CSB cells and cell extracts are deﬁcient in incision at
8-oxoguanine and 8-oxoadenine lesions (8–9,44) suggest-
ing that CSB may play a role in the repair of these lesions.
These lesions are believed to be removed by BER, and
there is additional evidence for a role of CSB in the
general genome BER pathway (45). Additional evidence
comes from studies in mouse models (46) where increased
accumulation of 8-oxoG is observed when mice are
deﬁcient in OGG1 in addition to lacking CSB. Also
CSB is in protein complex with OGG1 (44) although
8-oxo-G appears to be removed by general genome BER,
and there is no indication of transcription coupled repair
of this lesion (47). This deﬁciency in 8-oxoguanine incision
activity is complemented by ectopic expression of WT
CSB; the deﬁciency is partially complemented by a motif
II CSB mutant (ATPase deﬁcient, E646Q) but not
complemented by motif VI (Q942E) CSB mutants.
(8,9,44). This result suggests that domain VI of CSB is
required for repair of oxidative DNA lesions such as
CSB
c-Abl
WT E646Q VEC Q942E
c-Abl
CSB
A
B
IP:CSB, IB:p-Tyr
IP:c-Abl, IB:p-Tyr
IP:CSB, IB:CSB
IP:c-Abl, IB:c-Abl
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STI-571
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IP:c-Abl
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Figure 6. Oxidative damage induces c-Abl activation and CSB phosphorylation by c-Abl. Oxidative damage induces activation of c-Abl and Abl-
mediated phosphorylation of CSB, which is dependent on the ATPase function of CSB. Whole cell extracts were collected from CS1AN cells
complemented with either wild-type CSB, or ATPase-deﬁcient E646Q (motif II) mutant or motif VI (BER-deﬁcient) Q942E mutant of CSB. 1. No
treatment, 2. 250mmH 2O2, and 3. 24h pre-treatment with STI-571 (5mM)þ250mMH 2O2. Anti-CSB or anti-c-Abl immunoprecipitates were
collected from 250mg whole cell extracts and subjected to SDS page. The resultant membranes were either blotted with (A) anti-p-tyrosine or
(B) anti-CSB (top panel) and anti-c-Abl (bottom panel). (C) Whole cell extracts were collected from primary ﬁbroblasts from control subjects
(GM00969 and AG08470) or from CS patients (AG05012 and AG01428) treated either with 250 mmH 2O2 or 24h pre-treatment with STI-571
(5mM)þ250mMH 2O2. Anti-CSB or anti-c-Abl immunoprecipitates were collected from 250mg whole cell extracts and subjected to SDS page. The
resultant membranes were either blotted with anti-p-tyrosine, anti-CSB or anti-c-Abl antibodies. (D) Activation of c-Abl after H2O2. Whole cell
extracts were collected from CS1AN cells complemented with either wild-type CSB or empty vector treated either with 250mmH 2O2 or 24h pre-
treatment with STI-571 (5mM)þ250mMH 2O2. Kinase assay was done using immunocomplexed c-Abl and GST–Crk (aa 120–225). The product was
analyzed either for phosphotyrosine (1st panel, c-Abl; 2nd panel, GST–Crk) or for c-Abl (3rd panel) or CSB (4th panel). The arrows on the
p-Tyrosine panels of c-Abl represent 145kDa c-Abl protein while the second band represents 119kDa v-Abl isoform which also comes down with
8E9 antibody.
Nucleic Acids Research, 2007, Vol. 35, No. 15 49498-oxoguanine. It is interesting to note that Tyr932, the site
of c-Abl mediated tyrosine phosphorylation of CSB,
also resides in domain VI of CSB protein.
In cells exposed to oxidative stress, c-Abl auto-
phosphorylation and its phosphorylation of CSB
increases. However, these eﬀects are reduced and a lower
extent of phosphorylation occurs in cells expressing the
motif VI (Q942E) CSB mutant. CSB motif II is also
required for these phosphorylation events, because they
do not increase in response to oxidative damage in cells
expressing a motif II CSB mutant or in cells lacking CSB.
CSB is also required for oxidative stress-induced phos-
phorylation of Crk, a previously characterized substrate of
c-Abl. This ﬁnding of the requirement of CSB in the
activation of c-Abl during oxidative damage might have
a greater role in the understanding of mechanisms
of leukemia in CML patients. A constitutively active
Abl and Bcr-abl feature the physiology of CML (48).
Furthermore, a disruption of the CSB gene product has
been reported as a possible anti-cancer target (49,50). It is
possible that the disruption of CSB might help in the
inactivation of Abl in case of CML. In addition, the lack
of skin cancer in CSB patients might be due to the fact
that because of lack of CSB in these patients, activation
of c-Abl is hindered inhibiting the process of onset
of carcinogenesis. These ﬁndings suggest that CSB may
regulate auto-phosphorylation and activation of c-Abl in
response to oxidative stress and it might play a role in the
development of cancer. In addition, we also speculate that
tyrosine phosphorylated CSB may play a speciﬁc role in
regulating the response to oxidative DNA damage.
This study also shows that CSB and c-Abl co-localize in
the nucleus and re-distribute in the nucleolus in cells
treated with H2O2. This co-localization is inhibited by pre-
treatment with STI-571. The redistribution of c-Abl and
CSB may facilitate interaction between the two proteins
and tyrosine phosphorylation of CSB. Alternatively,
phosphorylation of CSB might promote its redistribution
to sites of oxidative damage; this is consistent with the
observation that redistribution of CSB and c-Abl is
inhibited by STI-571. Furthermore, c-Abl and CSB do
not co-localize to the nucleolus in unstressed cells,
suggesting that activation of c-Abl may play a role in
initiating redistribution. In future experiments, CSB
tyrosine 932 mutants could be used to determine the role
of c-Abl mediated tyrosine phosphorylation of CSB in the
process of CSB redistribution and in the response to
oxidative stress.
In conclusion, our results suggest that c-Abl interacts
with and tyrosine phosphorylates CSB. This interaction
may play an important role in the response to oxidative
stress, resulting in activation of c-Abl, tyrosine phosphor-
ylation of CSB and more eﬃcient BER of oxidative DNA
damage. Tyrosine-phosphorylated CSB may serve as a
signal for repair proteins to localize to DNA damage and
may help maintain active transcription in the nucleolus.
These data also provide a ﬁrst insight into a novel possible
role of CSB as a signaling molecule in response to
oxidative damage. This role can further be exploited to
understand the phenotype of CS as well as in a general
understanding of the role of CSB in response to various
oxidative and DNA damage. Further studies are needed to
understand the impact of tyrosine phosphorylation on the
physiologically important functions of CSB in vivo.
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